Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H21N3O4 |
| Molecular Weight | 379.4091 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@H]1NC(=O)N(C1=O)C2=CC=C(OC3=C4C(OCC45CC5)=C(C)C=C3)N=C2
InChI
InChIKey=NPNNMBCPDXXEAG-CQSZACIVSA-N
InChI=1S/C21H21N3O4/c1-3-14-19(25)24(20(26)23-14)13-5-7-16(22-10-13)28-15-6-4-12(2)18-17(15)21(8-9-21)11-27-18/h4-7,10,14H,3,8-9,11H2,1-2H3,(H,23,26)/t14-/m1/s1
| Molecular Formula | C21H21N3O4 |
| Molecular Weight | 379.4091 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 14:23:47 GMT 2025
by
admin
on
Wed Apr 02 14:23:47 GMT 2025
|
| Record UNII |
QZ8ETV7QYU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
939923
Created by
admin on Wed Apr 02 14:23:47 GMT 2025 , Edited by admin on Wed Apr 02 14:23:47 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
QZ8ETV7QYU
Created by
admin on Wed Apr 02 14:23:47 GMT 2025 , Edited by admin on Wed Apr 02 14:23:47 GMT 2025
|
PRIMARY | |||
|
1380696-69-4
Created by
admin on Wed Apr 02 14:23:47 GMT 2025 , Edited by admin on Wed Apr 02 14:23:47 GMT 2025
|
PRIMARY | |||
|
67959994
Created by
admin on Wed Apr 02 14:23:47 GMT 2025 , Edited by admin on Wed Apr 02 14:23:47 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET->MODULATOR |
|
||
|
|
TARGET->MODULATOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
